Michael F. Burgess Spring Works Therapeutics, Inc. (SWTX) insider trading activity

Michael F. Burgess is Head of Research & Development of SpringWorks Therapeutics, Inc.. Currently has a direct ownership of 49,584 shares of SWTX, which is worth approximately $1.92 Million. The most recent transaction as insider was on Jul 18, 2022, when has been sold 3,103 shares (Common Stock) at a price of $28.47 per share, resulting in proceeds of $88,342. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 49.6K

0% 3M change

0% 12M change

Total Value Held $1.92 Million

Michael F. Burgess Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 18 2022	SELL Payment of exercise price or tax liability	$88,342 $28.47 p/Share	3,103 Reduced 5.89%	49,584 Common Stock
Jun 30 2022	BUY Grant, award, or other acquisition	-	12,185 Added 18.78%	52,687 Common Stock
Jun 01 2022	SELL Payment of exercise price or tax liability	$52,398 $19.61 p/Share	2,672 Reduced 6.19%	40,502 Common Stock
Jan 06 2022	BUY Grant, award, or other acquisition	-	15,674 Added 26.63%	43,174 Common Stock
Jun 01 2021	BUY Grant, award, or other acquisition	-	27,500 Added 50.0%	27,500 Common Stock

Also insider at

SYBX

SYNLOGIC, INC. Healthcare

TSBX

Turnstone Biologics Corp.

Interim Chief Medical Officer

MFB